0001615219-19-000039.txt : 20190913 0001615219-19-000039.hdr.sgml : 20190913 20190913061654 ACCESSION NUMBER: 0001615219-19-000039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190910 FILED AS OF DATE: 20190913 DATE AS OF CHANGE: 20190913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arthur David J. CENTRAL INDEX KEY: 0001769331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36812 FILM NUMBER: 191091514 MAIL ADDRESS: STREET 1: 2450 HOLCOME BLVD. STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001615219 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465087339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 346-772-0346 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 FORMER COMPANY: FORMER CONFORMED NAME: Flex Pharma, Inc. DATE OF NAME CHANGE: 20140730 4 1 wf-form4_156836979901866.xml FORM 4 X0306 4 2019-09-10 0 0001615219 Salarius Pharmaceuticals, Inc. SLRX 0001769331 Arthur David J. C/O SALARIUS PHARMACEUTICALS, INC. 2450 HOLCOME BLVD., SUITE J-608 HOUSTON TX 77021 1 1 0 0 Chief Executive Officer Stock Option (right to buy) 8.0 2019-09-10 4 A 0 30000 0 A 2029-09-10 Common Stock 30000.0 30000 D The grant has a 4-year vesting schedule with 25% vesting on September 30, 2020 and 1/12th of the balance vesting on the last day of each calendar quarter thereafter. /s/ David J. Arthur 2019-09-10